| Literature DB >> 30111801 |
Alison Roth1, Swamy R Adapa1, Min Zhang1, Xiangyun Liao1, Vishal Saxena2, Raaven Goffe1, Suzanne Li1, Ratawan Ubalee3, Gagandeep S Saggu4, Zarna R Pala2, Shilpi Garg2, Silas Davidson3, Rays H Y Jiang5, John H Adams6.
Abstract
Malaria parasites transmitted by mosquito bite are remarkably efficient in establishing human infections. The infection process requires roughly 30 minutes and is highly complex as quiescent sporozoites injected with mosquito saliva must be rapidly activated in the skin, migrate through the body, and infect the liver. This process is poorly understood for Plasmodium vivax due to low infectivity in the in vitro models. To study this skin-to-liver-stage of malaria, we used quantitative bioassays coupled with transcriptomics to evaluate parasite changes linked with mammalian microenvironmental factors. Our in vitro phenotyping and RNA-seq analyses revealed key microenvironmental relationships with distinct biological functions. Most notable, preservation of sporozoite quiescence by exposure to insect-like factors coupled with strategic activation limits untimely activation of invasion-associated genes to dramatically increase hepatocyte invasion rates. We also report the first transcriptomic analysis of the P. vivax sporozoite interaction in salivary glands identifying 118 infection-related differentially-regulated Anopheles dirus genes. These results provide important new insights in malaria parasite biology and identify priority targets for antimalarial therapeutic interventions to block P. vivax infection.Entities:
Mesh:
Year: 2018 PMID: 30111801 PMCID: PMC6093925 DOI: 10.1038/s41598-018-30713-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Experimental design for RNA-sequencing of P. vivax salivary gland sporozoites (PvSGSs) and transcriptome comparison to different stage-specific Plasmodium species. (a) PvSGSs are aseptically dissected under an hour into respective experimental microenvironments (B1 = RPMI, B2 = RPMI + 3% BSA, B3 = Schneider’s, B4 = Schneider’s + 3% BSA) with no requirement of purification. Time point 0 h begins immediately after mosquito dissections where PvSGSs are measured in a gliding motility assay and a primary human hepatocyte invasion (PHH) assay with samples simultaneously collected for RNA-seq. This process is repeated for 2 additional time points; (4 h post-dissection at RT and 4 h post-dissection at 37 °C). (b) Sporozoites transcriptomes show overall similarities between P. vivax, P. falciparum, and P. yoelii. Different sporozoites transcriptomes generated in different labs in different species show overall similarities with Kendall’s tau >0.5; and they are less similar to other liver-stage related datasets, like hypnozoite transcriptomes, and oocytes transcriptomes. The datasets generated in this study are shaded yellow. The dendrographs represent the dataset relationships based on correlation of orthologue expression levels. (c) Orthologous gene expression levels in Plasmodium liver-stage parasites. Sporozoites enriched genes like CelTos, SPECT1, and TRAP are highly expressed in sporozoites in different Plasmodium species. Gene expression levels were normalized within sample as expression level ranks for comparisons.
Figure 2P. vivax salivary gland sporozoite (PvSGS) microenvironment linked to transcriptome signatures. (a) Three phenotypic groups were indicated in RNA-seq analysis, quiescent, invasion activated, and early liver-stage, which were determined through differential gene expression induced by serum component albumin and temperature shift from RT to 37 °C. (b) Pearson’s correlation of all RNA-seq samples shows temperature shift serves as the major trigger for PvSGSs transition to early liver-stage parasites. (c) Distinct calcium signaling cascades are identified as PvSGSs transition where calmodulin, CDPK 1, 4, 6 are influential in PvSGSs invasion with presence during quiescent state while calmodulins, formin, CDPK7, and PAST1 are implemented with roles in early liver-stage parasite development. (d) Gene Ontology (GO) enrichment analysis were performed on sporozoite quiescent state (red) and early liver-stage state (brown) with emphasis on cellular components, molecular function, and biological processes where bar graphs are indicating fold enrichment with a P ≤ 0.05.
Figure 3Human body temperature and albumin serves as triggers for sporozoite motility while insect microenvironment maintains sporozoite viability. (a) Imaged P. vivax salivary gland sporozoites (PvSGSs) exhibit gliding motility in all experimental microenvironments upon rupture from salivary glands during 0 h post-dissection, 37 °C (T0, 37 °C). (b) PvSGSs maintained for 4 h post-dissection at room temperature (RT) retain gliding motility in microenvironments induced by buffered mediums containing BSA (RPMI + 3% BSA and Schneider’s + 3% BSA), or in insect-like media, Schneider’s. (c) PvSGSs in mammalian-like microenvironment (RPMI) reactivate gliding motility when maintained 4 h post-dissection, RT and subjected to a 30 min induction at 37 °C (d) Only PvSGSs maintained in insect-like microenvironment (Schneider’s) show circular motility patterns 4 h post-dissection,37 °C. (e) Representative images of PvSGSs gliding motility at 0 h and 4 h post-dissection, 37 °C. A standard sandwich immunofluorescence assay (IFA) based on the monoclonal anti-circumsporozoite protein (CSP) antibody was used to visualize sporozoite motility where manual quantification (from 10 fields of view or 1,000 total PvSGSs) was used to measure sporozoite metrics (percent gliding, motility path). All images were captured at 20x magnification, 0.74 NA. Scale bars (white) represent 10 µM. Graph bars represent mean with s.d for experimental replicates (n = 10) and biological replicate (n = 3) from 10 fields of view or 1,000 PvSGSs. Statistical significance was calculated using a two-way ANOVA with Tukey’s multiple comparisons test to all means where statistical significance values are represented as P < 0.05 (*), P < 0.001 (***), and P < 0.0001 (****). (Blue = RPMI, Purple = RPMI + 3% BSA, Green = Schneider’s, Orange = Schneider’s + 3% BSA).
Figure 4Hepatocyte culture media (HCM) increases P. vivax salivary gland sporozoites (PvSGSs) invasion of primary human hepatocytes (PHHs). (a) The 0 h post-dissection (−) hepatocyte culture media (HCM) refers to PvSGSs collected, diluted, and inoculated in PHHs using respective experimental media and no addition of HCM where all showed low formation of liver-stage parasites. (b) PvSGSs diluted in HCM containing non-heat inactivated serum (0 h post-dissection, (+) HCM) show increased liver-stage parasite development with highest rates in sporozoites dissected into Schneider’s. (c) PvSGSs show a decrease in liver-stage parasite development following an incubation at RT (room temperature) for 4 h post-dissection compared to 0 h post-dissection, (+) HCM) where the mammalian media-based microenvironment (RPMI) had the lowest rates. (d) PvSGSs maintained for 4 h post-dissection at 37 °C lack liver-stage parasite development in mammalian media-based microenvironments (RPMI and RPMI + 3% BSA) while sporozoites in insect media-based microenvironments (Schneider’s and Schneider’s + 3% BSA) retain PHH infectivity. (e) Representative image of a P. vivax developing schizont on day 8 post-infection while (f) is a representative image of a day 8 P. vivax hypnozoite where both are positively stained by anti-UIS4 and anti-GAPDH. All PHH invasion assays were performed with 5.0 × 103 sporozoites per well inoculum with fixation on day 8 post-infection. Graph bars represent means with s.d for experimental replicates (n = 5 or 6) and biological replicates (n = 3). Statistical significance was calculated using a two-way ANOVA with Tukey’s multiple comparisons test to all means where statistical significance values are represented as P < 0.05 (*), P < 0.005 (**), P < 0.001 (***), P < 0.0001 (****). Scale bars white represent 10 µm and grey represent 5 µm. (Blue = RPMI, Purple = RPMI + 3% BSA, Green = Schneider’s, Orange = Schneider’s + 3% BSA).
30 genes with annotations most highly up-regulated in quiescent P. vivax sporozoites.
|
|
|
|
|
|---|---|---|---|
| PVP01_1105500 | nucleoside diphosphate kinase, putative | NDK | <0.0001 |
| PVP01_1132600 | TRAP-like protein, putative | TLP | <0.0001 |
| PVP01_0613800 | merozoite TRAP-like protein, putative | MTRAP | <0.0001 |
| PVP01_1226800 | nicotinamide/nicotinic acid mononucleotide adenylyltransferase, putative | NMNAT | 0.0093 |
| PVP01_1124400 | sphingomyelin synthase 2, putative | SMS2 | 0.0160 |
| PVP01_0607900 | phospholipid scramblase, putative | 0.0003 | |
| PVP01_1258000 | gamete egress and sporozoite traversal protein, putative | GEST | 0.0143 |
| PVP01_1249700 | thioredoxin 1, putative | TRX1 | <0.0001 |
| PVP01_0920900 | CorA-like Mg2+ transporter protein, putative | MIT1 | <0.0001 |
| PVP01_1245400 | phosphatidylinositol-4-phosphate 5-kinase, putative | PIP5K | <0.0001 |
| PVP01_0615300 | claudin-like apicomplexan microneme protein, putative | CLAMP | <0.0001 |
| PVP01_1224800 | apicoplast calcium binding protein 1, putative | ACBP1 | <0.0001 |
| PVP01_1436800 | thrombospondin-related apical membrane protein, putative | TRAMP | 0.0010 |
| PVP01_1321700 | CorA-like Mg2+ transporter protein, putative | MIT3 | 0.0003 |
| PVP01_1212700 | iron regulatory protein, putative | IRP | <0.0001 |
| PVP01_0114800 | serine/threonine protein kinase, FIKK family | FIKK | <0.0001 |
| PVP01_0943700 | alpha/beta hydrolase, putative | alpha/beta hydrolase | <0.0001 |
| PVP01_0928000 | tRNA (guanine-N (7)-)-methyltransferase, putative | tRNA (guanine-N (7)-)-methyltransferase | <0.0001 |
| PVP01_0728800 | merozoite surface protein 1 paralog | MSP1P | 0.0010 |
| PVP01_1223600 | protein kinase, putative | PK | <0.0001 |
| PVP01_0313300 | calcium-dependent protein kinase 4, putative | CDPK4 | 0.0014 |
| PVP01_1141700 | uroporphyrinogen III decarboxylase, putative | UROD | <0.0001 |
| PVP01_1456100 | COPI associated protein, putative | COPI | <0.0001 |
| PVP01_1464100 | DNA replication origin binding protein, putative | DIA2 | 0.0007 |
| PVP01_0112200 | plasmepsin X, putative | PMX | <0.0001 |
| PVP01_1322600 | phosphoenolpyruvate carboxylase, putative | PEPC | 0.0171 |
| PVP01_0303900 | 6-cysteine protein, putative, pseudogene | 6-cys | <0.0001 |
| PVP01_0921000 | alpha/beta hydrolase fold domain containing protein, putative | alpha/beta hydrolase | <0.0001 |
| PVP01_0519100 | vacuolar protein sorting-associated protein 2, putative | VPS2 | 0.0002 |
| PVP01_0906300 | centrin-4, putative | CEN4 | <0.0001 |
This table represents differentially expressed genes (0 h vs 4 h, 37 °C) with exclusion of unannotated genes.
Refer to Supplemental Data S3 for complete data set.
Genes with annotations most highly up-regulated in activated P. vivax sporozoites.
|
|
|
|
|
|---|---|---|---|
| PVP01_0407500 | calcium-dependent protein kinase 1, putative | CDPK1 | 0.0285 |
| PVP01_1032700 | conserved Plasmodium protein, unknown function | 0.0229 | |
| PVP01_0806900 | rho GTPase-activating protein, putative | 0.0247 | |
| PVP01_1427900 | sporozoite surface protein 3, putative | SSP3 | 0.0054 |
| PVP01_0521100 | acylated pleckstrin-homology domain-containing protein, putative | APH | 0.0084 |
| PVP01_0938800 | sporozoite surface protein essential for liver stage development, putative | SPELD | 0.0225 |
| PVP01_0414200 | syntaxin, Qa-SNARE family, putative | SYN17 | 0.0001 |
| PVP01_1461700 | ADP-ribosylation factor GTPase-activating protein, putative | ARFGAP | 0.0118 |
| PVP01_0508000 | SPRY domain, putative | 0.0118 | |
| PVP01_0940400 | adrenodoxin reductase, putative | 0.0008 | |
| PVP01_1236500 | conserved Plasmodium protein, unknown function | 0.0147 | |
| PVP01_1461800 | conserved Plasmodium protein, unknown function | 0.0104 | |
| PVP01_1010500 | DnaJ protein, putative | 0.0477 | |
| PVP01_1423500 | calmodulin, putative | 0.0074 | |
| PVP01_1262000 | conserved Plasmodium protein, unknown function | 0.0052 | |
| PVP01_1460500 | conserved Plasmodium protein, unknown function | 0.0048 |
This table represents differentially expressed genes (0 h vs 4 h, 37 °C) with exclusion of unannotated genes.
Refer to Supplemental Data S3 for complete data set.
30 genes with annotations most highly up-regulated in P. vivax sporozoites transitioning into early liver-stage parasites.
|
|
|
|
|
|---|---|---|---|
| PVP01_0616100 | ookinete surface protein P25 | Pvs25 | 0.0001 |
| PVP01_0929800 | parasitophorous vacuolar protein 1, putative | PV1 | 0.0070 |
| PVP01_1444300 | haloacid dehalogenase-like hydrolase, putative | HAD3 | 0.0063 |
| PVP01_1255700 | E3 SUMO-protein ligase NSE2, putative | NSE2 | 0.0001 |
| PVP01_0905900 | histone 2B, putative | H2B | <0.0001 |
| PVP01_1131700 | histone H2A, putative | H2A | <0.0001 |
| PVP01_1130100 | cell division cycle protein 48 homologue, putative | 0.0025 | |
| PVP01_1330600 | calmodulin, putative | 0.0001 | |
| PVP01_1265900 | KS1 protein precursor, putative | 0.0171 | |
| PVP01_1267100 | triosephosphate isomerase, putative | 0.0206 | |
| PVP01_0816000 | enolase, putative | ENO | 0.0034 |
| PVP01_0815800 | tubulin binding cofactor c, putative | 0.0310 | |
| PVP01_1255200 | sortilin, putative | 0.0080 | |
| PVP01_0713100 | major facilitator superfamily-related transporter, putative | MFR4 | 0.0057 |
| PVP01_1238100 | eukaryotic initiation factor 4a, putative | eIF4A | 0.0002 |
| PVP01_0905800 | histone H4, putative | H4 | 0.0026 |
| PVP01_0507600 | receptor for activated c kinase, putative | RACK1 | 0.0237 |
| PVP01_0808500 | nucleolar protein 5, putative | NOP5 | 0.0066 |
| PVP01_1208500 | DNA/RNA-binding protein Alba 2, putative | ALBA2 | 0.0004 |
| PVP01_1212100 | DNA-directed RNA polymerases I, II, and III subunit RPABC4, putative | RPB12 | 0.0059 |
| PVP01_0515500 | U3 small nucleolar ribonucleoprotein protein IMP4, putative | IMP4 | 0.0081 |
| PVP01_0811500 | proteasome subunit beta type-5, putative | 0.0064 | |
| PVP01_1302200 | high mobility group protein B1, putative | HMGB1 | 0.0104 |
| PVP01_1429700 | ATP-dependent RNA helicase DBP1, putative | DBP1 | <0.0001 |
| PVP01_1207600 | nucleoside transporter 1 | NT1 | 0.0001 |
| PVP01_1432600 | proline–tRNA ligase, putative | PRS | 0.0406 |
| PVP01_1022800 | stearoyl-CoA desaturase, putative | SCD | 0.0001 |
| PVP01_1266000 | cytoplasmic tRNA 2-thiolation protein 2, putative | NCS2 | 0.0431 |
| PVP01_0825400 | RING finger protein RNF1, putative | <0.0001 | |
| PVP01_0504400 | sporozoite invasion-associated protein 2, putative | SIAP2 | 0.0025 |
This table represents differentially expressed genes (RPMI, 0 h vs. RPMI 4 h, 37 °C) with exclusion of unannotated genes.
Refer to Supplemental Data S3 for complete data set.
Figure 5Characterization of the Anopheles dirus salivary gland transcriptome. Differential expression analysis revealed up-regulation of 23 genes with known functions in mosquito immune factors, metabolism, apoptosis inhibition, structural, and olfactory proteins along with 28 genes down-regulated with functions as solute transporters, protein synthesis, salivary gland enzymes, and DNA repair (averaged infected vs average uninfected, FPKM ≥ 20, P ≤ 0.05).
Genes with annotations most highly up-regulated and down-regulated in P. vivax infected and uninfected Anopheles dirus mosquitoes.
|
|
|
|
|
|
|---|---|---|---|---|
|
| ||||
| ADIR00790 | alpha-crystallin B chain | alpha-crystallin B chain | Apoptosis inhibitor | <0.0001 |
| ADIR007941 | unknown function/alpha-crystallin B chain | alpha-crystallin B chain | 0.0001 | |
| ADIR010798 | defensin anti-microbial peptide | defensin | Immunity | <0.0001 |
| ADIR006825 | gambicin anti-microbial peptide | gambicin | <0.0001 | |
| ADIR014587 | attacin anti-microbial peptide | attacin | 0.0016 | |
| ADIR003751 | C-type lectin | CTL | 0.0004 | |
| ADIR007855 | leucine-rich immune protein (Long) | LRIM | 0.0004 | |
| ADIR008083 | leucine-rich immune protein (Long) | LRIM | 0.0026 | |
| ADIR003752 | C-Type Lectin | CTL | 0.0001 | |
| ADIR005185 | SP14D1 | SP14D1 | <0.0001 | |
| ADIR007695 | serine protease SP24D | SP24D | 0.0207 | |
| ADIR002798 | CLIP-domain serine protease | CLIPs | <0.0001 | |
| ADIR000960 | peptidoglycan-recognition protein | PGRP | 0.0001 | |
| ADIR007771 | ficolin A | ficolin A | 0.0016 | |
| ADIR006371 | trehalose 6-phosphate phosphatase | T6P | Protein Catabolism | 0.0001 |
| ADIR011634 | flavin-containing monooxygenase | FMO | <0.0001 | |
| ADIR008936 | diamine acetyltransferase | DAT | <0.0001 | |
| ADIR003836 | cysteine dioxygenase | CDO | <0.0001 | |
| ADIR008493 | threonine dehydratase | TDH | 0.0010 | |
| ADIR001408 | 4a-hydroxytetrahydrobiopterin dehydratase | OH-BH | 0.0379 | |
| ADIR007539 | phenylalanine-4-hydroxylase | PAH | 0.0023 | |
| ADIR003591 | peritrophin | peritrophin | Structural | 0.0152 |
| ADIR010042 | odorant binding protein | OBP | Olfaction | 0.0168 |
| ADIR002153 | pacifastin-related peptide | Unknown | 0.0025 | |
|
| ||||
| ADIR014650 | salivary gland protein | SGP | Salivary gland enzyme | 0.0062 |
| ADIR007445 | alpha-amylase | AA | 0.0002 | |
| ADIR003224 | salivary gland protein | SGP | 0.0002 | |
| ADIR004887 | 23.4 kDa salivary protein | SGP | 0.0215 | |
| ADIR001653 | duplex-specific nuclease | DSN | DNA repair | <0.0001 |
| ADIR000534 | protein disulfide-isomerase | PDI | Protein synthesis | 0.0431 |
| ADIR003326 | translation initiation factor 1 A | eIF-1a | 0.0411 | |
| ADIR002569 | alpha-tocopherol transfer protein-like protein | TTPAL | 0.0311 | |
| ADIR004227 | eukaryotic translation initiation factor 3 subunit E | eIF-3E | 0.0215 | |
| ADIR001129 | elongation factor 1-gamma | EF1G | 0.0116 | |
| ADIR004002 | dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit 1 | DDOST | 0.0122 | |
| ADIR009737 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase | GalNAc-T | 0.0112 | |
| ADIR003797 | eukaryotic translation initiation factor 3 subunit L | eIF-3L | 0.0011 | |
| ADIR001338 | small ubiquitin-related modifier | SUMO | 0.0296 | |
| ADIR000499 | translocase of outer mitochondrial membrane 20 homolog | TOMM20 | 0.0054 | |
| ADIR009264 | alpha-12C2-Mannosidase | MAN12C2 | 0.0362 | |
| ADIR009439 | carboxylic ester hydrolase | CEH | Protein catabolism | 0.0019 |
| ADIR010119 | carboxylic ester hydrolase | CEH | <0.0001 | |
| ADIR010296 | serine incorporator | SERINC | Transporter | 0.0109 |
| ADIR009494 | V-type proton ATPase proteolipid subunit | V-ATPase | 0.0165 | |
| ADIR006128 | +V-type H+-transporting ATPase 21kDa proteolipid subunit | V-ATPase | 0.0107 | |
| ADIR004742 | proton-coupled amino acid transporter | PAT | 0.0007 | |
| ADIR006703 | sodium-independent sulfate anion transporter | SLC | 0.0007 | |
| ADIR004547 | V-type H+-transporting ATPase subunit E | V-ATPase | 0.0148 | |
| ADIR010593 | V-type proton ATPase catalytic subunit A | V-ATPase | 0.0245 | |
| ADIR000034 | solute carrier family 15 member | SLC15 | 0.0196 | |
| ADIR008886 | signal recognition particle subunit SRP54 | SRP54 | Immunity | 0.0046 |
| ADIR007705 | C-type lectin | CTL | 0.0161 | |
The table represents differentially expressed genes of infected vs. uninfected salivary glands with exclusion of unannotated genes.
Refer to Supplemental Data S9 and S10 for complete data sets.